Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Location details updated: New York and Washington sites added; related location sections adjusted and the HHS disclosure link removed (revision v3.3.3).
    Difference
    0.3%
    Check dated 2025-12-23T09:55:18.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T18:55:18.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed the government funding operating status notice from the page, including references to cc.nih.gov and opm.gov. This notice previously informed users about potential delays in updates; its removal does not affect the study details presented.
    Difference
    0.4%
    Check dated 2025-11-17T18:01:55.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Comparison shows no changes to core study information (title, conditions, interventions, eligibility criteria, and outcomes). Any differences are limited to layout and visual presentation.
    Difference
    0.4%
    Check dated 2025-11-03T12:42:10.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:30:17.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:52:11.000Z thumbnail image

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.